SURVYR

CMPS

COMPASS Pathways plc
$11.81
+$0.76 (6.88%)Oct 27 close
Healthcare CompareTechnicals
1M3M6M1Y2Y
-25%+17%+59%+101%+143%Oct 2025Oct 2026Apr 202652w high $15.8752w low $4.88
CMPSSPY
Wall St. Highest PT $65.00 (+450.4%) Wall St. Avg PT $23.75 (+101.1%)
$5$20$36$51$67POC $12Hi $65Avg $24
Underwater Drawdown %Max DD -38.2%Current -22.3%
0.0%-38.2%
Relative Strength vs SPY+67.0% vs SPYOutperforming
+140%0%-140%
1W
−$0.09 (0.76%)
1M
−$1.25 (9.57%)
3M
+$0.96 (8.85%)
6M
+$3.37 (39.93%)
YTD
+$4.91 (71.16%)
1Y
+$5.27 (80.58%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Wall Street analyst consensus
SellHoldStrong Buy
Strong Buy
16 analysts · mean score 1.31
1 = Strong Buy · 5 = Sell
Wall Street consensus
Analyst price targets
Current price$11.81
Average target$23.75
+$11.94 (+101.1%) upsideaverage target vs current price
CurrentAverageMedian
Low$13.00
Median$23.75
High$65.00
12-month Wall Street target range
Recent analyst rating changes · 8
Reiterated
2026-08-07 · HC Wainwright & Co. reiterated Buy on CMPS
Reiterated
2026-08-06 · Morgan Stanley reiterated Overweight on CMPS
Reiterated
2026-08-06 · RBC Capital reiterated Outperform on CMPS
Reiterated
2026-08-06 · B. Riley Securities reiterated Buy on CMPS
Initiated
2026-07-27 · Wells Fargo started covering CMPS at Equal-Weight
Reiterated
2026-07-08 · HC Wainwright & Co. reiterated Buy on CMPS
All analyst rating changes ›

Third-party ratings, not SURVYR.'s views.

Key stats & company

Market value$1.6B
P/E (next 12 months, estimated)-8.3
52-week range$4.88 – $15.87
Dividend yieldNo dividend
Analyst consensusStrong Buy (16)
Average analyst price target$23.75 (+101%)

What they do

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was incorporated in 2020 and is headquartered in London.

Healthcare · Medical Care Facilities
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

No sector grades for CMPS yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth
Outside this model's universe or screens
 Momentum Top 15
Outside this model's universe or screens
 Momentum Blend
Not in the current book
 New Highs Growth
Outside this model's universe or screens
 SURVYR. Barbell Momentum & T-Bill Shield
Outside this model's universe or screens
 SURVYR. Physical AI Grid & Power
Outside this model's universe or screens
 SURVYR. Long Book
Not in the current book

Earnings & events

CMPS earningsNext report in 6 days
Next report · quarter Sep 2026
Tue Nov 3, 2026Before the open
EPS consensus-$0.33 range -$0.41–-$0.25
Revenue consensus$0 14 analysts
Last 4 quarters · EPS vs estimate
Aug 5, 2026-$0.36est -$0.33−6.6%Below estimates
May 13, 2026-$0.30est -$0.31+3.2%Above estimates
Mar 24, 2026-$0.61est -$0.39−55.5%Below estimates
Nov 4, 2025-$0.38est -$0.40+5.3%Above estimates

In line = within 1% of the estimate.

Source: Yahoo Finance · refreshed 2026-10-21 18:14:16 ET
24-1025-0225-0525-0725-1126-0326-0526-08-0.640.00
EstimateActual (beat)Actual (miss)

Quarterly revenue

QuarterRevenueYoY
2026-06-30$0–
2026-03-31$0–
2025-12-31$0–
2025-09-30$0–
2025-06-30$0–

News & catalysts

More news
Cybin Eyes Q4 Phase III Depression Data as Anxiety Program Advances
MarketBeat · Oct 21
COMPASS Pathways (CMPS) Stock May Trade At A Premium After Positive Phase 3 Results
Simply Wall St. · Oct 17
Compass Pathways Joins Forces with Leading Mental Health Organizations to Mark First-Ever U.S. Treatment-Resistant Depression (TRD) Awareness Day
Business Wire · Oct 14
Cathie Wood-Led Ark Invest Sells AMD, SPCX, GOOG Stocks — But Loads Up On CMPS, NTLA, CRSP And Other Healthcare Firms
Stocktwits · Oct 10
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire · Oct 02
Rating changes
Reiterated
2026-08-07 · HC Wainwright & Co. reiterated Buy on CMPS
Reiterated
2026-08-06 · Morgan Stanley reiterated Overweight on CMPS
Reiterated
2026-08-06 · RBC Capital reiterated Outperform on CMPS
Reiterated
2026-08-06 · B. Riley Securities reiterated Buy on CMPS
Initiated
2026-07-27 · Wells Fargo started covering CMPS at Equal-Weight
Reiterated
2026-07-08 · HC Wainwright & Co. reiterated Buy on CMPS

Third-party analyst actions, not SURVYR.'s views. All rating changes

Insider trades
None
None · None
Sell
–

Stats refreshed 2026-10-21 18:14:16 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksOur promiseTermsPrivacyData statusSend feedback
Coteau 0.9 · Oct 21, 2026